SCHEMBL6901016

SCHEMBL6901016

COc1ccc2c(c1)[C@H](c1ccc(OCCN3CCCC3)cc1)[C@H](c1cccc(O)c1)CO2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 17/20 0.71
ESR2 Q92731 16/20 0.71
CHRM2 P08172 2/20 0.55
ADRA2A P08913 2/20 0.55
ADORA3 P0DMS8 2/20 0.55
CHRM1 P11229 2/20 0.55
SLC6A2 P23975 2/20 0.55
SLC6A4 P31645 2/20 0.55
ADRA1A P35348 2/20 0.55
DRD3 P35462 2/20 0.55
SLC6A3 Q01959 2/20 0.55
KCNH2 Q12809 2/20 0.55
HRH3 Q9Y5N1 2/20 0.55
MLNR O43193 1/20 0.55
NR1I2 O75469 1/20 0.55
NR3C1 P04150 1/20 0.55
ADRB1 P08588 1/20 0.55
DRD2 P14416 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8165814 1.00 ESR1 (0.71) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL6901014 1.00 ESR1 (0.71) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL7505124 0.94 ESR1 (0.78) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL7505122 0.94 ESR1 (0.78) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL7508663 0.93 ESR1 (0.65) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL7508657 0.93 ESR1 (0.65) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL6898861 0.90 ESR1 (0.72) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL6898865 0.90 ESR1 (0.72) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL6901987 0.90 ESR1 (0.72) ESR1ESR2CHRM2ADRA2AADORA3
SCHEMBL7022819 0.89 ESR1 (0.89) ESR1ESR2CHRM2ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937058-A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES NOVO NORDISK A/S (DK) 1999-08-25 EP claimed
WO-1998018773-A1 NOVEL CIS-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES NOVO NORDISK A/S (DK) 1998-05-07 WO claimed
EP-1465619-A1 SUPPRESSION OF CARTILAGE DEGRADATION VIA THE ESTROGEN RECEPTOR Nordic Bioscience A/S (DK) 2004-10-13 EP disclosed
WO-2003063859-A1 SUPPRESSION OF CARTILAGE DEGRADATION VIA THE ESTROGEN RECEPTOR NORDIC BIOSCIENCE A/S (DK) 2003-08-07 WO disclosed
US-6043269-A ESTROGEN AGONISTS NOVO NORDISK A/S (DK) 2000-03-28 US disclosed